Pneumonectomy for malignant disease: factors affecting early morbidity and mortality.

Date publication

juin 2001

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BERNARD Alain

Tous les auteurs :
Bernard A, Deschamps C, Allen MS, Miller DL, Trastek VF, Jenkins GD, Pairolero PC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/11385374

Résumé

OBJECTIVE: The purpose of this report is to analyze factors affecting morbidity and mortality after pneumonectomy for malignant disease. METHODS: We retrospectively reviewed the cases of all patients who underwent pneumonectomy for malignancy at the Mayo Clinic. Between January 1, 1985, and September 30, 1998, 639 patients (469 men and 170 women) were identified. Median age was 64 years (range 20 to 86 years). Indication for pneumonectomy was primary lung cancer in 607 (95.0%) patients and metastatic disease in 32 (5.0%). Factors affecting morbidity and mortality were analyzed by univariate and multivariate analysis. RESULTS: Cardiopulmonary complications occurred in 245 patients (38.3%; 95% confidence interval 34.6%-42.2%). Factors adversely affecting morbidity with univariate analysis included age (P

Référence

J Thorac Cardiovasc Surg. 2001 Jun;121(6):1076-82.